Items 1 to 10 of 12 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This cytidine analog may interfere with the methylation pattern of the OR52N4 gene's promoter region, potentially leading to its transcriptional silencing if methylation is ordinarily required for its expression. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
As an inhibitor of histone deacetylases, Trichostatin A could result in the hyperacetylation of histones near the OR52N4 gene, possibly leading to the compacting of chromatin and subsequent transcriptional repression of this gene. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $85.00 | 9 | |
This compound could cause hyperacetylation of histones associated with the OR52N4 gene, which may result in chromatin condensation and a subsequent decrease in OR52N4 expression levels. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Retinoic Acid could activate transcription factors that repress the OR52N4 gene, leading to reduced transcriptional activity and lower protein levels. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
This antibiotic binds to the DNA helix, obstructing RNA polymerase action on the OR52N4 gene, which would result in decreased mRNA synthesis and protein production. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $92.00 $209.00 | 33 | |
By inhibiting dihydrofolate reductase, Methotrexate could disrupt one-carbon metabolism, leading to altered methylation patterns and potential downregulation of OR52N4 expression. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $54.00 | 6 | |
If the OR52N4 gene promoter encompasses Sp1-binding sites, Mithramycin A could bind these sequences, blocking Sp1 transcription factor access and leading to decreased OR52N4 transcription. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $68.00 | 2 | |
Chloroquine could inhibit lysosomal enzymes and alter the endosomal system, which may disrupt mRNA trafficking or degradation pathways, potentially leading to reduced levels of OR52N4 mRNA. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $42.00 $72.00 $124.00 $238.00 $520.00 $1234.00 | 11 | |
EGCG could bind directly to the DNA of the OR52N4 gene or interact with transcription factors specific to the OR52N4 promoter, leading to a targeted reduction in gene expression. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
By inhibiting the PI3K pathway, which may be involved in the transcriptional activation of OR52N4, LY294002 could lead to a decrease in the expression of the OR52N4 gene. |